Epigenomics
Volume 14, 2022 - Issue 17
Review
Telomere Therapy for Chronic Kidney Disease
Olutope Arinola Akinnibosun1 Health Innovation and Transformation Centre, Federation University Australia, Ballarat, Victoria, Australia
https://orcid.org/0000-0001-8113-4454View further author information
https://orcid.org/0000-0001-8113-4454View further author information, Michelle C Maier1 Health Innovation and Transformation Centre, Federation University Australia, Ballarat, Victoria, Australiahttps://orcid.org/0000-0002-9197-602XView further author information
https://orcid.org/0000-0002-9197-602XView further author information, James Eales2 Division of Cardiovascular Sciences, University of Manchester, Manchester, UKhttps://orcid.org/0000-0001-6238-5952View further author information
https://orcid.org/0000-0001-6238-5952View further author information, Maciej Tomaszewski2 Division of Cardiovascular Sciences, University of Manchester, Manchester, UK;3 Manchester Heart Centre and Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, UKhttps://orcid.org/0000-0001-8215-6567View further author information
https://orcid.org/0000-0001-8215-6567View further author information & Fadi J Charchar1 Health Innovation and Transformation Centre, Federation University Australia, Ballarat, Victoria, Australia;4 Department of Cardiovascular Sciences, University of Leicester, Leicester, UK;5 Department of Anatomy and Physiology, University of Melbourne, Melbourne, Victoria, AustraliaCorrespondence[email protected]
https://orcid.org/0000-0002-6164-9941View further author information
https://orcid.org/0000-0002-6164-9941View further author information